Fritextsökning
Innehållstyper
-
Astra Zeneca dumpar projekt inom blodsjukdomar – tar miljardsmäll
Astra Zeneca lägger ner ett läkemedelsprojekt inom sällsynta blodsjukdomar och tar en avsevärd ekonomisk smäll: en nedskrivning på 753 miljoner dollar, motsvara...
-
Collaboration for a simpler production of gene therapies launched
A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by J...
-
Göran Stiernstedt: “We are the world’s worst at continuity”
. “It makes me extremely frustrated,” he says.
-
Non-destructive testing and assembly control
Assess complete assembly.
-
Anders Blanck about his 17 years at Lif: “The industry is enjoying greater public trust now"
. However, I will turn 56 this autumn, and if I’m going to do something else in my professional life, now is the time,” he says.
-
WuXi AppTec, UK Ltd
-
Double up for Korbinian Löbmann
This year, Korbinian Löbmann will moderate the New Updates in Drug Formulation & Bioavailability meeting in Copenhagen for the fifth time. Furthermore, he will ...
-
AI-Driven Microscopy Image Analysis in Pharma and Biotech
Extract breakthrough discoveries from large, complex data sets.
-
Conjugate Planes in Microscopy
Knowledge Article from ZEISS.
-
AZ gets approval for drug targeting rare disease – it may reduce cortisone dependence
AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.
-
Bought a tablet factory – and built his own empire
In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...
-
Lonza
-
Speed meets precision for high-density components
ZEISS METROTOM 800 320 kV.
-
High-performance Slide Scanner for Fluorescence, Brightfield and Polarization
ZEISS Axioscan 7.
-
Lucy Robertshaw: Artificial intelligence – is this really going to transform a patient’s life?
In a column Lucy Robertshaw reflects on how AI and new regulations will affect healthcare, innovation and the lives of future patients.
-
ProPharma
-
SGS Fimko Ltd.
-
Genes from Neanderthals can affect the correct drug dosage
A fifth of all Europeans carry gene variants inherited from Neanderthals, which cause certain drugs to break down more slowly. This may have implications for th...
-
Fundamental Aspects of Airy Disk Patterns
Knowledge Article from ZEISS.
-
Sweden is organising a large life science conference as part of the EU presidency
On 26-27 June, Sweden will host a European meeting on life science.
-
QPS Netherlands B.V
-
Tirzepatide approved for obesity by the FDA – to be branded as Zepbound
Diabetes drug tirzepatide has now also been approved in the US for treating obesity.
-
Webinar: Can AI replace humans in pharmacovigilance?
The webinar will explore how AI can transform pharmacovigilance by enhancing efficiency, reducing errors, and addressing challenges such as software costs, data...
-
Wusson Accelerator AB